The reason being that it takes a lot of time and money to bring a new drug to market. Hundreds of millions in many cases. And the cost to create a generic version is very low. Think tens of thousands. And the time even lower (think weeks).
So you have a situation where you can spend $300M over 5 years to create a new drug (due to various regulations in bringing a drug to market), which will have generic competition in two months after release. That makes doing that type of drug research a non-starter. It's not like the drug maker can just keep improving the drug.
That doesn't happen in most other industries, where your 1 year of research and development largely gives you a 3-6 month advantage (you can release whatever you want, whenever you want). And you can then continue to improve the product at a brisk rate, building on what you've done. Google today is not the Google from a decade ago. They've taken their technology and improved it at a rapid rate, such that the current product is magnitudes better. You can't do that for most drugs.
I, however, don't know enough about alternative business models to say if they make any sense.
We shouldn't be using patent-free file formats, that have made compromises to be patent-free. We should be fighting to end patents (except for medicine). The best thing we can ask This American Life, or ProPublica, or Planet Money, or Marketplace to do, is to air more shows about the problems patents cause.
This type of act by the FSF is the type of thing that gets some guy at the office to say, "I told you. These people just want you to use Ogg on your Linux computer running on some patent unecumbered CPU (couldn't think of one). They're just not realistic."